Showing results (41-50 of 62) with videos related to
Sort By:
Pageof 7
Plos One|April 25, 2012
Electrocardiographic left ventricular hypertrophy and outcome in hemodialysis patientsSeung Jun Kim, Hyung Jung Oh, Dong Eun Yoo, et al.Bioorganic & Medicinal Chemistry Letters|October 18, 2011
Design and synthesis of triazolopyridazines substituted with methylisoquinolinone as selective c-Met kinase inhibitorsJae Wook Ryu, Sun-Young Han, Jeong In Yun, et al.Archives of Pharmacal Research|January 22, 2014
ALK inhibitors of bis-ortho-alkoxy-para-piperazinesubstituted-pyrimidines and -triazines for cancer treatmentHyeon Ji Lee, Muhammad Latif, Hyeonjeong Choe, et al.Archives of Pharmacal Research|January 13, 2016
Discovery of substituted pyrazol-4-yl pyridazinone derivatives as novel c-Met kinase inhibitorsEun-Young Kim, Seung-Tae Kang, Heejung Jung, et al.The Journal of Clinical Endocrinology and Metabolism|June 23, 2012
Preservation of renal function by thyroid hormone replacement therapy in chronic kidney disease patients with subclinical hypothyroidismDong Ho Shin, Mi Jung Lee, Seung Jun Kim, et al.Journal of Critical Care|October 23, 2012
Early initiation of continuous renal replacement therapy improves patient survival in severe progressive septic acute kidney injuryHyung Jung Oh, Dong Ho Shin, Mi Jung Lee, et al.Yonsei Medical Journal|May 28, 2013
Stepwise treatment using corticosteroids alone and in combination with cyclosporine in korean patients with idiopathic membranous nephropathyDong Ho Shin, Mi Jung Lee, Hyung Jung Oh, et al.Kidney International|August 17, 2012
Clinical outcomes, when matched at presentation, do not vary between adult-onset Henöch-Schönlein purpura nephritis and IgA nephropathyHyung Jung Oh, Song Vogue Ahn, Dong Eun Yoo, et al.Investigational New Drugs|November 17, 2010
Evaluation of a multi-kinase inhibitor KRC-108 as an anti-tumor agent in vitro and in vivoSun-Young Han, Chong Ock Lee, Sung-Hoon Ahn, et al.Bioorganic & Medicinal Chemistry Letters|August 4, 2015
Synthesis and evaluation of novel 2,4-diaminopyrimidines bearing bicyclic aminobenzazepines for anaplastic lymphoma kinase (ALK) inhibitorGa Ae Kang, Minji Lee, Dawn Song, et al.Pageof 7